ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

In Brief: Smyth Moves From AOR To Bristol-Myers; Lurie Center Wins Grants From Army, NCI

December 13, 1996

Clinical Research Group Of ACCC Meets

April 24, 1981